Although cranial neuropathi es are common disorders in multiple sclerosis pati ents, multiple cranial nerve involvement is an unusual occurrence. Correlation ofclinical symptoms with magnetic resonan ce imag ing evidence ofdemyelinating central nervous system lesions can con--f irm the diagnosis. The autho rs report on the case ofa 43year-old woman who initially \Vas thought to have suff ered a brain stetn infa rct but, in f act, had developed mult iple cranial nerve functional defi cits. Treatment of multiple sclerosis remain s primarily suppo rtive in nature, with corticosteroids used for acute exacerbations and chronic progression. "Department of Ot olaryngology-Head and Nec k Surger y. Mad iga n Army Med ica l Cen ter , Taco ma. Washin gton. "Department of Oto lar yngology -Head and Ne ck Surgery , Wa lter Reed Army Medical Ce nter. Wa shington, DC.
Introduction
Multiple sclerosis (MS) is a ch roni c neurologic disease with significa nt variability in clinical severity and expr ession.!' Although the development of cranial neuropathies in MS patients is a com mon finding, the se disorders tend to appear later in the course of the disease and rarely have been reported to invo lve multiple cranial ner ves.
We present an unu sual case of mult iple cranial ner ve functional deficits in a pati ent who init ially was presumed to have suffered a brain stem infarct. Ma gnetic resonan ce imagi ng (MRI) revealed a mult iplicity of lesions with a waxing-and-waning appea rance on serial studies. Th ese findings and suppo rtive laboratory data were most consis-tent with a demy elinating disease pro ce ss and the diagnosis of MS was made.
Case Report
A 43-year-old woman ca me to the emergency dep artment complaining of new onset diplopia, mild dy sphagia, right-side decreased hearing acu ity and muscular weakness. Th e patient fir st noted the se symptoms two days before the day of admissi on. She denied any verti go , paresthesia s or recent viral symptom s.
Phy sical exa mination revealed a well-dev eloped white wo man who was afebrile, had stable vital sig ns and was in no ap parent distress. Th e neurologic exa mination was sig nifica nt for horizont al nystagmu s of the left eye. A right lateral rectus muscle pal sy was noted as well as a sluggis h pupill ary reflex . Th e left pup il was norm ally reactive.
Th e patient had complete rig ht lower moto r neuron distribut ion facial paral ysi s and right faci al paresthe sia in the distributi on of all divisions of the fifth cranial nerve. Additionally, she had decre ased hea ring acuity and loss of the gag reflex on the right, with tongu e deviation to that side on protrusion. Hypopharyngeal inspection revealed norm al true vocal cord mobility with no ev ide nce of masses or lesion s. Th e re main der of the head and neck examination was unremarkable.
A mild paresis of the right upper extremity and weakness with dimini shed vibratory sensation in the right lower extremity wer e dem onstrated. Her deep tend on refl exes were br isk throughout , and no add itional focal deficits were noted on neurolo gic exa m.
The pat ient was takin g warfarin sodium (Co umadin) for a history of two episo des of deep vein thrombophlebitis. No other significant pre vious health co nditions were ident ified , and she was admitted to the neurology service with a working diagn osis of brainstem ischem ia. Computed tom ograph y (CT) revealed no evide nce of hemor-ENT-Ear, Nose & Throat Journal" February 1999 CRANIAL POLYNEUROPATHIES IN MULTIPLE SCLEROSIS: CASE REPORT AND LITERATURE REVIEW rhage or optic nerve impingem ent. MRI showed a poorl y circumscrib ed right middle cerebellar peduncle lesion that failed to enhance wi th gado linium contras t ( Figure I ). Cerebrospinal flu id tested negati ve for oligoclo nal antibodies, and the myel in basic protein level was marginally pos itive at 7.4 nglm l. Based on these findings, the differential dia gnoses included infarction, tumor or dem yelinatin g processes. Supportive ca re was provided, and her ph ysic al co ndition gra dually improved with near-t otal res olution of her symptoms. On hospit al day 10, j ust before transfer to a rehabilitation facility, her sta tus acutely deteriorated . Ph ysical exa minatio n revealed a unil ateral pal sy of cranial nerves V throu gh XII.
MRI dem on strated inter val enlargemen t of the right middl e cer ebellar pedu ncle lesion with an are a of increased attenuation in the occi pital horn of the right ven tricle ( Figure 2 ). Th ere was enhanced signal in the occ ipital pole periventricular region , with ev ide nce of a mass effect ( Figure 3 ). Repe at lumb ar puncture revealed oligoclona l band s and moderate eleva tion of the myelin basic protein level to II nglml.
Th e clinical, laboratory and serial MRI evi de nce was consistent wi th MS. Anticoagulation medi cation was discontinued and high-dose meth ylp redn isolone therap y initiated. A tracheo stom y and a feedin g gas tros tomy tube were required . With agg ressive daily occ upatio na l and physical therap y, the patient demonstrated significa nt clinica l recovery over the next few days. A final MRI obt ained on hospit al day 20 revealed a decre ased T2 signal and contrast enha ncement co mpared with earlier studies (Figure 4) .
Th e remai ning four weeks of hospit alization were uneventful; the patient continued to show progressive recovery of neurologic functi ons. Her visual sy mptoms and paresth esias had resol ved . Th e facia l nerve exami nation result was consistent with a Hou se-Brackmann grade III paralysis, and the hypoglossal nerve paresis was unchanged.
Audi ologic evaluation co nfir med normal bilate ral hearin g acu ity, and the pati ent ' s gag reflex and speec h articulation were sig nifica ntly improved. Ambulating with the assistance of a walker, she was mo ved to a rehabilitation facility. One year after discharge, the patient had persistent , mild right facial paresis with continued decreased right hyp oglo ssal nerve functio n manifested by mod er ate ton gue hemi atrophy. Th e rem ain ing neurologic functio ns had obj ect ively and subjective ly improve d, and the patient almos t had attai ned her prehospitalization activi ty level. To date, she continues physic al and occupa tional therapy and has had no recurrent ex acerbations.
Discussion
MS is the most common demyelin ating disease of the central nervou s sys tem (CNS) . Usually affectin g yo unge r pati ent s, MS is character ized by exacerbatio ns and re mis- sions. Alth ough the exac t etiology rem ains unknown , vario us enviro nme ntal fac tors are likely to be involved in the path ogenesis. I·> Since Charcot's original description;' the diagnosis has been prim arily a clin ical determination made in conj unc-tion with laboratory test result s. T he advent of magnetic reso nance imagi ng permitted the demonstrat ion of lesions within the white matter of the CNS, which correlated wit h vario us cli nica l symptoms seen in affected patient s." ? Maj or adva ntages of MRI when co mpared with clinical monitoring are the ability to detect a sig nificant amo unt of subcli nica l disease activity and the ability to mo nitor the efficacy of MS therapy by detec ting active lesions.Y Altho ugh MS remains a common disorder primaril y affecting the CN S myelin, studies have co nfir med the existence of peripheral nervou s sys tem myelin deficit s." Whereas cranial nerve impairmen ts may be man ifes t in thi s disease, ex te nsive cra nia l po lyne uro pathies are rare occ urre nces . A review of the medica l literature revealed no reports of profound, acu te neuro logic deficits invo lving multiple cra nial nerves in a si ngle patien t.
In this case, the initial MRI examination dem onstrated a poo rly circ umscribed middl e ce rebe llar peduncle lesion that did not enha nce with gado linium co ntrast (Fig ure I) . Based on thi s appearance and location , the differenti al diagnos is included infarction , a dem yelin ating neurologic disease or a tum or, suc h as as trocytoma or glio blastoma multi forme.
Serial MRI evaluations dem on strated a minimal incre ase in mass effect ove r a three-week period . Th e degree of mass effect was less than what wou ld be ex pected for a neoplastic lesion of this size (Figure 4 ). An infarct wo uld likely have revealed a volume loss in the span of three weeks . T his lesion location did not conform to an arterial vasc ular terr itory, which made the diagn osis of infarction impro bable. Furtherm ore, the rapi d clinical deterioration seen in thi s case was not charac ter istic of a neopl asm .
Th e MR images obtained on hospit al day 9 revealed a markedl y abnormal T2 signal and co ntrast enhance me nt that was not previou sly evide nt (Fig ures 2, 3 ). Sub sequent images indi cated a paucity of these findi ngs . Th e subarachnoid spre ad of a neoplastic process, such as glio blastom a multifor me, wo uld not be ex pec ted to di ssipate as in th is case. These lesion s, with periven tricular involvem ent and waxi ng-a nd-wani ng appearance on ser ial exa ms are most co nsistent with the diagnosis of a dem yelinating disease process.
Dem yel inating foci, or plaqu es, are co nsidered to be the ca usative fac to rs res po nsible for the sy mp toms and fin dings of MS. Periventr icu lar foci invo lving the lateral fourth ve ntricle are co mmo n, and plaqu es may be present in the spina l co rd, midbra in, pon s and basal ga nglia. function manifested by dipl opia may be a prese nting symptom. Acute third ner ve palsy with pupill ary involvement also has been cited as a presen ting sign of MS. 7 -IO Var ious sensory signs and sympto ms are frequen tly found in affec ted individuals. Paresthesias of a porti on of the trige minal nerve distribut ion are fairly common , whereas motor roo t involvement is considered to be a relatively rare occurrence.v" Seventh cranial nerve palsies in MS patients have a reported incidence of 15%. Facial motor function abn ormalities were similarl y re po rte d b y M ulle r " and Grenrnan.!' The basis for treatm ent of MS remains genera l suppor tive care. Corticos teroids are useful for acute relapse s and for treating chronic progression of the disease. " Additional immunosuppress ive agents including cyclo phospha mide (Cytox an), azathioprine (l mura n) and interfe ron beta-l b have been used in various clinical studies . Interferon l-a, a recombinant form of hum an interferon beta, recently has been approve d by the U.S. Food and Drug Administration for the treatment of patient s experie ncing relap sing form s of MS. 15 The exact mech ani sm of action of these agen ts in treating MS rem ain s uncl ear. 
